Costello C E, Brodack J W, Jones A G, Davison A, Johnson D L, Kasina S, Fritzberg A R
J Nucl Med. 1983 Apr;24(4):353-5.
The nature of two technetium-labeled radiopharmaceutical components has been established by means of fast-atom-bombardment mass spectrometry (FABMS) in combination with carrier-added (CA) and no-carrier-added (NCA) reversed-phase high-pressure liquid chromatography (HPLC). Negative-ion FABMS was used to determine that the epimers of Tc-CO2DADS are the oxo[N,N'-(1-carboxyethylene)-bis-(2-mercaptoacetimido)]technetate(V) ions; positive-ion FABMS showed that Tc-HIDA is bis[N-(2,6-dimethylphenyl-carbamoylmethyliminodiaceto]technetate(III).
通过快原子轰击质谱法(FABMS)结合加载体(CA)和无载体(NCA)反相高压液相色谱法(HPLC),已确定了两种锝标记的放射性药物成分的性质。负离子FABMS用于确定Tc-CO2DADS的差向异构体为氧代[N,N'-(1-羧基乙烯基)-双-(2-巯基乙酰亚氨基)]锝(V)离子;正离子FABMS表明,Tc-HIDA为双[N-(2,6-二甲基苯基-氨基甲酰甲基亚氨基二乙酸)]锝(III)。